⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TVTX News
Travere Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
TVTX
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
TVTX
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
TVTX
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
businesswire.com
TVTX
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm
globenewswire.com
TVTX
TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
prnewswire.com
TVTX
TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses
globenewswire.com
TVTX
TVTX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
businesswire.com
TVTX
INVESTOR ALERT: Investigation of Travere Therapeutics, Inc. (TVTX) by Holzer & Holzer, LLC
globenewswire.com
TVTX